NCT07716969

Brief Summary

This study examines whether an early-detection program for psychosis can shorten the time patients remain untreated after the first appearance of psychotic symptoms, and whether such a reduction improves later functioning for people with first-episode schizophrenia. Psychosis involves symptoms such as hallucinations and delusions. When these symptoms are recognized and treatment begins, most patients improve. However, many individuals live with psychotic symptoms for months-or even longer-before receiving care. This period is known as the duration of untreated psychosis (DUP). A long DUP has repeatedly been linked to poorer long-term outcomes, but it is still unclear whether DUP itself causes worse outcomes or simply reflects different illness courses. In Denmark, Region Zealand has implemented a large-scale early-detection effort. This includes public awareness campaigns and a specialized team that identifies people with emerging psychosis and helps them start treatment quickly. The Capital Region of Denmark provides usual care without these additional initiatives. This situation makes it possible to compare two regional systems that differ in their approach to early detection but provide the same specialized treatment once patients enter care. The study follows a quasi-experimental design, recruiting adults (18+) who receive a first diagnosis of a schizophrenia-spectrum disorder within the OPUS early-intervention programs in the two regions. No interventions are assigned by the research team; participants receive standard clinical care. Researchers conduct interviews to establish how long psychotic symptoms were present before treatment began and to assess functioning and symptoms over a two-year follow-up period. Functioning, symptoms, cognition, and treatment factors will be examined at baseline and at follow-ups. The study addresses three questions: Whether early-detection efforts in Region Zealand reduce the duration of untreated psychosis compared with usual detection. Whether a shorter duration of untreated psychosis leads to better functional and clinical outcomes fifteen months after treatment begins. How DUP can best be defined and measured so that it reliably predicts later outcomes. Results may provide evidence for whether early-detection services improve timely access to care and whether reducing the duration of untreated psychosis contributes to better long-term functioning. The study may also help establish clearer international standards for how DUP should be measured in both research and clinical practice.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
250

participants targeted

Target at P75+ for all trials

Timeline
25mo left

Started Mar 2024

Longer than P75 for all trials

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress55%
Mar 2024Jul 2028

Study Start

First participant enrolled

March 1, 2024

Completed
2.4 years until next milestone

First Submitted

Initial submission to the registry

July 16, 2026

Completed
5 days until next milestone

First Posted

Study publicly available on registry

July 21, 2026

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2026

Expected
1.6 years until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2028

Last Updated

July 21, 2026

Status Verified

July 1, 2026

Enrollment Period

2.8 years

First QC Date

July 16, 2026

Last Update Submit

July 16, 2026

Conditions

Keywords

Duration of Untreated PsychosisEarly DetectionPsychosisSchizophrenia

Outcome Measures

Primary Outcomes (2)

  • Duration of Untreated Psychosis measured with the NOS

    From start inclusion, marts 2024, to end inclusion marts 2027

  • PSP

    Personal and Social Performance Scale

    From beginning of 15 months follow-up, May 2025, until end of follow-up, September 2028

Study Arms (2)

Cohort 1: Region Zealand Early-Detection Cohort

Participants identified through in a region with a early-detection program, which could identify participants prior to OPUS treatment

Other: No intervention (Observational Study)

Cohort 2: Capital Region Usual-Detection Cohort

Cohort 2: Capital Region Usual-Detection Cohort

Other: No intervention (Observational Study)

Interventions

Participants receive standard clinical care independent of the study. No intervention is assigned by investigators.

Cohort 1: Region Zealand Early-Detection CohortCohort 2: Capital Region Usual-Detection Cohort

Eligibility Criteria

Age18 Years - 35 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Patients are recruted within the first 9 months of their OPUS treatment in the Capital region or Region Zealand.

You may qualify if:

  • or older In treatement in an OPUS treatment center in The Capital Region or Region Zealand.
  • Started OPUS treatment within the last 9 months Suspected to have a psychotic disorder within the ICD 10 Schizophrenia spectrum (DF2X, excluding schizotypal disorder and schizophrenia simplex) Able to communicate adequately regarding symptoms and functioning in Danish or English.

You may not qualify if:

  • IQ bellow 70 I primary diagnoses of drug or alcohol dependency

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Mental Health Centre Copenhagen

Copenhagen, Denmark, 2900, Denmark

RECRUITING

Region Zealand Psychiatry East

Roskilde, Denmark, 4000, Denmark

RECRUITING

MeSH Terms

Conditions

Psychotic DisordersSchizophrenia

Interventions

Observation

Condition Hierarchy (Ancestors)

Schizophrenia Spectrum and Other Psychotic DisordersMental Disorders

Intervention Hierarchy (Ancestors)

MethodsInvestigative Techniques

Study Officials

  • Nikolai Albert

    Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Nikolai Albert, MD, PhD

CONTACT

Stephen F Austen, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
18 Months
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate professor

Study Record Dates

First Submitted

July 16, 2026

First Posted

July 21, 2026

Study Start

March 1, 2024

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

July 31, 2028

Last Updated

July 21, 2026

Record last verified: 2026-07

Data Sharing

IPD Sharing
Will share

Data will after completion of the study be transferred in the Danish National Archives, where from they can be requested and delivered in accordance with Danish data protection laws.

Shared Documents
STUDY PROTOCOL
Time Frame
01.01.2030, no end data
Access Criteria
The National archives will make decision based on national data protection laws.
More information

Locations